Fetal health assessment in utero by laboratory technologies: Clinical benefits, risks and controversies
Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA. Clinical biochemistry
(Impact Factor: 2.28).
05/2011; 44(7):460-2. DOI: 10.1016/j.clinbiochem.2011.03.015
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.